Cheri L. Lubahn, Ph.D.
|2001||Arizona State University, Tempe, AZ, United States|
Area:Immunology, Neuroscience Biology
Mean distance: 53433
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Rahman S, Gadjeva M. (2014) Does NETosis Contribute to the Bacterial Pathoadaptation in Cystic Fibrosis? Frontiers in Immunology. 5: 378|
|Lubahn CL, Lorton D, Schaller JA, et al. (2014) Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis. Frontiers in Immunology. 5: 346|
|Perez SD, Kozic B, Molinaro CA, et al. (2012) Chronically lowering sympathetic activity protects sympathetic nerves in spleens from aging F344 rats. Journal of Neuroimmunology. 247: 38-51|
|Lorton D, Lubahn CL, Zautra AJ, et al. (2008) Proinflammatory cytokines and sickness behavior in rheumatic diseases. Current Pharmaceutical Design. 14: 1242-60|
|Lorton D, Lubahn CL, Estus C, et al. (2006) Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep. Neuroimmunomodulation. 13: 357-74|
|Lubahn CL, Schaller JA, Bellinger DL, et al. (2004) The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis. Brain, Behavior, and Immunity. 18: 563-71|